About Hospital Universitario Rio Hortega; Servicio de Oftalmologia
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hospital Universitario Rio Hortega; Servicio de Oftalmologia
During the past decade, Hospital Universitario Rio Hortega; Servicio de Oftalmologia conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on
average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40%
of trials that started reached the finish line.
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
2014-07-22
2023-12-31
Active, not recruiting
280
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Rio Hortega; Servicio de Oftalmologia"
#1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hospital Universitario Rio Hortega; Servicio de Oftalmologia
According to Clinical.Site data, the most researched conditions in "Hospital Universitario Rio Hortega; Servicio de Oftalmologia" are
"Geographic Atrophy" (3 trials), "Diabetic Macular Edema" (2 trials), "Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials) and "Central Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Hospital Universitario Rio Hortega; Servicio de Oftalmologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitario Rio Hortega; Servicio de Oftalmologia
Most popular intervention types in "Hospital Universitario Rio Hortega; Servicio de Oftalmologia" are "Drug" (9 trials), "Other" (4 trials), "Procedure" (4 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "Lampalizumab" (2 trials) and "No intervention" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitario Rio Hortega; Servicio de Oftalmologia
The vast majority of trials in "Hospital Universitario Rio Hortega; Servicio de Oftalmologia" are
10 trials for "All" genders.
Clinical Trials Status at Hospital Universitario Rio Hortega; Servicio de Oftalmologia
Currently, there are NaN active trials in "Hospital Universitario Rio Hortega; Servicio de Oftalmologia".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hospital Universitario Rio Hortega; Servicio de Oftalmologia,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitario Rio Hortega; Servicio de Oftalmologia, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".